External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

External reports (aggregated public sources)

Value Investors Club

Equity Bottom-Up

Key points (machine generated)<ul><li>Femasys specializes in minimally invasive solutions for women's reproductive health, targeting a $3 billion market.</li><li>The company has FDA clearance and CE marking for four products, including FemaSeed and FemBloc, which is in pivotal trials.</li><li>Femasys faces liquidity risks due to convertible debt maturities but has a history of successful fundraising, presenting potential investment opportunities.</li></ul>This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Key points (machine generated)Femasys specializes in minimally invasive solutions for women's reproductive health, targeting a $3 billion market.The company has FDA clearance and CE marking for four products, including FemaSeed and FemBloc, which is in pivotal trials.Femasys faces liquidity risks due to convertible debt maturities but has a history of successful fundraising, presenting potential investment opportunities.This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Femasys Inc (FEMY) - Wednesday, Jul 23, 2025

United States

Femasys Inc. operates as a biomedical company. The Company researches, develops, and manufactures novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. Femasys serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Femasys (FEMY US)

Femasys Inc (FEMY) - Wednesday, Jul 23, 2025

Femasys, a U.S. medical tech firm focused on women's reproductive health, has FDA-cleared products and faces liquidity risks but may offer a...

Value Investors Club (VIC)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)